Skip to main content

Advertisement

Table 1 Association between NOK expressions and clinicopathological features in NSCLC patients

From: Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer

Variables No. of cases NOK expression
Positive (%) Negative (%) P-value*
Sex     
Male 154 114 (74.0) 40 (26.0) 0.371
Female 37 30 (81.1) 7 (18.9)
Age     
<60 90 70 (77.8) 20 (22.2) 0.470
≥60 101 74 (73.3) 27 (26.7)
Smoking history     
Smoker 133 100 33 0.618
Non-smoker 58 42 16
Differentiation     
Well + moderately 140 100 (71.4) 40 (28.6) 0.035
Poorly 51 44 (86.3) 7 (13.7)
Histological type     
Squamous 98 71 (72.4) 27 (27.6) 0.332
Adenocarcinoma 93 73 (78.5) 20 (21.5)
pT factor     
T1–2 148 110 (74.3) 38 (25.7) 0.525
T3–4 43 34 (79.1) 9 (20.0)
pN factor     
N0 88 58 (65.9) 30 (34.1) 0.005
N1–2 103 86 (83.5) 17 (16.5)
pTNM stage     
I-II 128 90 (70.3) 38 (29.7) 0.020
III-IV 63 54 (85.7) 9 (14.3)
Ki-67 labeling index     
<31 94 57 (60.6) 37 (39.4) <0.001
≥31 97 89 (91.8) 8 (8.2)
  1. *P-value of χ2-test are shown.